COMPAGNIE D'EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE
SIREN 493265284
No insolvency procedure
No collective procedure published in the BODACC window loaded by Solvenda. Monitoring continues daily.
Index compliant
- Score published : 93/100 (edition 2025)
- Previous edition (2024) : 93/100
- Headcount band : 1000 et plus
- Sector : Commerce et réparation automobile
- Department : Seine-Maritime
Source: Gender Equality Index published by the French Ministry of Labour, Open Licence 2.0. Absence from an edition may also mean the company left the obligation.
3 agreement(s) filed, 2 with a term date
| Agreement | Theme | Term |
|---|---|---|
| Egalité professionnelle entre les femmes et les hommes et la QVCT | Egalité salariale F/H | 1161 days (2029-11-03) |
| SALAIRES 2026 | Evolution des salaires (augmentation, gel, diminution) | 123 days (2026-12-31) |
| Classifications et évolution professionnelle | Classifications | no term |
Source: ACCO database of company agreements, DILA and Légifrance, Open Licence 2.0.
Solvenda watches for you, every morning.
Monitor this SIREN and your whole portfolio automatically.
Get started Risk index →Frequently asked questions
Is COMPAGNIE D'EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE in insolvency proceedings?
No collective procedure is published in the BODACC for SIREN 493265284 in the window loaded by Solvenda. This is not a solvency guarantee; monitoring continues daily.
Does the absence of a BODACC procedure guarantee solvency?
No. It only proves no insolvency procedure is published to date. Continuous monitoring by SIREN remains necessary.
What is the gender equality index of COMPAGNIE D'EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE?
COMPAGNIE D'EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE published a score of 93 for the 2025 edition. Below 75, a company has three years to correct, failing which a penalty of up to 1% of payroll may apply.
Does COMPAGNIE D'EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE have collective agreements?
3 company agreement(s) filed by COMPAGNIE D'EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE appear in the public ACCO database, of which 1 reach their term within twelve months.